Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Viatris Inc. VTRS

Healthcare  —  Drug Manufacturers Specialty & Generic
17.83 0.41 2.35% as of 25 Sep
Market cap
$20.0B
P/E
0.0×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Viatris Inc. (VTRS) Price to free cash flow

As of 25 September 2026, Viatris Inc. (VTRS) trades at a price to free cash flow of 11.0×. Over the past ten years it has ranged from 2.1× (April 2025) to 135× (July 2015); the current reading is higher than 57% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 16.5× and below the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 7.5× 125.96%
FY2024 3.3× (31.78%)
FY2023 4.9× (9.15%)
FY2022 5.4× (17.11%)
FY2021 6.5× (68.23%)
FY2020 20.4× 180.37%
FY2019 7.3× (39.38%)
FY2018 12.0× (34.66%)
FY2017 18.4× 18.63%
FY2016 15.5× (30.96%)

Quarterly

Period Price to free cash flow Change
Jun 2026 9.8× 7.77%
Mar 2026 9.1× 20.62%
Dec 2025 7.5× 6.77%
Sep 2025 7.0× 139.68%
42 more quarters

Against its own ten years

Low 2.1× High 135×
Ten-year median 9.1×
Current reading's percentile 57

Price to free cash flow against peers

Company Price to free cash flow
HLN Haleon PLC Sponsored ADR compare 9.4×
VTRS Viatris Inc. 11.0×
ZTS Zoetis Inc. compare 12.8×
NBIX Neurocrine Biosciences, Inc. compare 16.1×
UTHR United Therapeutics Corporation compare 18.6×
ELAN Elanco Animal Health Incorporated compare 31.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 32.6×
RDY Dr. Reddy's Laboratories Ltd compare 69.0×
HIMS Hims & Hers Health, Inc. compare 82.2×
Drug Manufacturers Specialty & Generic industry median 16.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on VTRS